Privium Fund Management B.V. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 3 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Privium Fund Management B.V. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$81,473
-47.1%
34,967
-48.3%
0.02%
-25.0%
Q2 2023$154,076
+23.9%
67,5770.0%0.03%
-23.8%
Q1 2023$124,342
-39.5%
67,577
-40.5%
0.04%
-46.2%
Q4 2022$205,486
-18.8%
113,5280.0%0.08%
-15.2%
Q3 2022$253,000
-9.3%
113,528
+15.2%
0.09%0.0%
Q2 2022$279,000
+102.2%
98,528
+198.6%
0.09%
+196.8%
Q1 2022$138,00033,0000.03%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$38,130,00036.42%
FRAZIER MANAGEMENT LLC 3,746,857$19,446,0001.50%
TFG Asset Management GP Ltd 2,700,000$14,013,0000.84%
Nantahala Capital Management 4,077,509$21,162,0000.74%
Ikarian Capital, LLC 544,819$2,827,0000.42%
HARBOR CAPITAL ADVISORS, INC. 211,319$1,097,0000.40%
Blackstone Inc. 17,985,611$93,345,0000.23%
Resolute Capital Asset Partners LLC 65,115$338,0000.22%
MYDA Advisors LLC 125,000$649,0000.17%
Eversept Partners, LP 401,540$2,083,9930.13%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders